Detalhe da pesquisa
1.
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
Cell
; 182(4): 843-854.e12, 2020 08 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32673567
2.
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
Cell
; 182(6): 1663-1673, 2020 09 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32946786
3.
Self-amplifying RNA vaccine protects mice against lethal Ebola virus infection.
Mol Ther
; 31(2): 374-386, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36303436
4.
Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination.
Proc Natl Acad Sci U S A
; 118(28)2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34162739
5.
Cyclophilin inhibitors restrict Middle East respiratory syndrome coronavirus via interferon-λ in vitro and in mice.
Eur Respir J
; 56(5)2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32616594
6.
Intranasal Borna Disease Virus (BoDV-1) Infection: Insights into Initial Steps and Potential Contagiosity.
Int J Mol Sci
; 20(6)2019 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30875911
7.
Cyclosporin A Reveals Potent Antiviral Effects in Preclinical Models of SARS-CoV-2 Infection.
Am J Respir Crit Care Med
; 205(8): 964-968, 2022 04 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35167409
8.
Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein.
J Virol
; 89(16): 8651-6, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26018172
9.
A Highly Immunogenic and Protective Middle East Respiratory Syndrome Coronavirus Vaccine Based on a Recombinant Measles Virus Vaccine Platform.
J Virol
; 89(22): 11654-67, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26355094
10.
T-bet+ B cells are activated by and control endogenous retroviruses through TLR-dependent mechanisms.
Nat Commun
; 15(1): 1229, 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38336876
11.
Short- and Long-Interval Prime-Boost Vaccination with the Candidate Vaccines MVA-SARS-2-ST and MVA-SARS-2-S Induces Comparable Humoral and Cell-Mediated Immunity in Mice.
Viruses
; 15(5)2023 05 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37243266
12.
Protective CD8+ T Cell Response Induced by Modified Vaccinia Virus Ankara Delivering Ebola Virus Nucleoprotein.
Vaccines (Basel)
; 10(4)2022 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-35455282
13.
Vaccine-associated enhanced respiratory pathology in COVID-19 hamsters after TH2-biased immunization.
Cell Rep
; 40(7): 111214, 2022 08 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35952673
14.
Increased neutralization and IgG epitope identification after MVA-MERS-S booster vaccination against Middle East respiratory syndrome.
Nat Commun
; 13(1): 4182, 2022 07 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35853863
15.
Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity.
J Clin Invest
; 132(24)2022 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36301637
16.
Post-viral effects of COVID-19 in the olfactory system and their implications.
Lancet Neurol
; 20(9): 753-761, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34339626
17.
Development and characterization of an indirect ELISA to detect SARS-CoV-2 spike protein-specific antibodies.
J Immunol Methods
; 490: 112958, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33412174
18.
Intranasal Administration of a Monoclonal Neutralizing Antibody Protects Mice against SARS-CoV-2 Infection.
Viruses
; 13(8)2021 07 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452363
19.
Osteogenesis imperfecta in a male holstein calf associated with a possible oligogenic origin.
Vet Q
; 40(1): 58-67, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31980012
20.
Safety and immunogenicity of a modified vaccinia virus Ankara vector vaccine candidate for Middle East respiratory syndrome: an open-label, phase 1 trial.
Lancet Infect Dis
; 20(7): 827-838, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32325037